Biomimetic Assembly of the Central Core of Halichonadins K and L
Geduran® Si 60 (particle size 40–63 mm) and Sephadex LH-20®
(Pharmacia) gels were used for column chromatography. NMR
spectra were recorded in [D5]pyridine with an AM-300 (300 MHz)
or AM-400 (400 MHz) Bruker spectrometer and calibrated by
using undeuterated pyridine as an internal reference. IR spectra
were recorded with a Vector 22 Bruker spectrometer. Mass spectra
were recorded at the “Service d’Analyse des Médicaments et des
Métabolites” (Université Paris-Sud).
combined organic layers were then dried with MgSO4, filtered, and
concentrated under reduced pressure. The crude residue was puri-
fied by flash chromatography on silica gel (CH2Cl2/MeOH, 98:2)
to provide 13 (50 mg, 61%) as an amorphous colorless solid. 1H
NMR (400 MHz, [D5]pyridine): δ = 1.06 (m, 2 H), 1.17–1.37 (8 H),
1.45 (m, 2 H), 1.55–1.70 (4 H), 1.75 (m, 2 H), 1.85–2.00 (8 H), 2.88
(t, J = 7.2 Hz, 2 H), 3.67 (m, 2 H), 3.70 (m, 2 H), 4.00 (m, 2 H),
4.21 (t, J = 6 Hz, 2 H), 7.23–7.32 (5 H), 8.37 (d, J = 7.6 Hz, 2 H),
8.76 (t, J = 5.6 Hz, 1 H) ppm. 13C NMR (75 MHz, [D5]pyridine):
δ = 20.2, 25.7, 26.2, 29.0, 33.6, 33.8, 36.7, 41.4, 48.6, 57.5, 61.9,
(R,S)-Methyl
2,6-Bis(cyclohexylcarbamoyl)piperidin-1-yl-acetate
(11): To a solution of glycine methyl ester hydrochloride (500 mg,
4.0 mmol) in MeOH (5 mL) was added a 4% aqueous solution of
citric acid followed by the addition of glutaraldehyde (480 mg,
4.8 mmol, 1.2 equiv., 870 μL of a 50% aqueous solution). The mix-
ture was stirred for 3 min at room temperature and then cyclohex-
ylisocyanide (890 μL, 8.0 mmol, 2 equiv.) was slowly added. The
resulting reaction mixture was then stirred for 48 h at room tem-
perature, diluted with H2O (40 mL), and extracted with CH2Cl2
(4ϫ 20 mL). The combined organic extracts were dried with anhy-
drous MgSO4, filtered, and evaporated under reduced pressure. The
residue was purified by flash chromatography on silica gel (cyclo-
hexane/ethyl acetate, 1:1 then 3:7) and by Sephadex® LH-20 col-
umn chromatography (MeOH/CH2Cl2, 1:1) to provide 11 as a col-
127.0, 129.2, 129.6, 140.4, 172.1, 173.6 ppm. IR (film): ν = 3200,
˜
2950–2900, 2854, 1640, 1527, 1451, 1250 cm–1. HRMS (TOF MS
ES+): calcd. for C29H45N4O3 [M + H]+ 497.3486; found 497.3491.
Supporting Information (see footnote on the first page of this arti-
1
cle): H NMR and 13C NMR spectra of compounds 11–13.
Acknowledgments
We thank Jean-Christophe Jullian for NMR assistance.
[1] Isolation of halichonadins K and L: N. Tanaka, S. Suto, H.
Ishiyama, T. Kubota, A. Yamano, M. Shiro, J. Fromont, J. Ko-
bayashi, Org. Lett. 2012, 14, 3498–3501.
[2] Isolation of halichonadin C: H. Ishiyama, A. Hashimoto, J.
Fromont, Y. Hoshino, Y. Mikami, J. Kobayashi, Tetrahedron
2005, 61, 1101–1105
[3] Isocyanide marine natural products, review article: M. J. Gar-
son, J. S. Simpson, Nat. Prod. Rep. 2004, 21, 164–179.
[4] Isocyanide biosynthetic studies, see for example: a) M. J. Gar-
son, J. S. Simpson, Org. Biomol. Chem. 2004, 2, 939–948; b)
S. F. Brady, J. Clardy, Angew. Chem. 2005, 117, 7225; Angew.
Chem. Int. Ed. 2005, 44, 7063–7065.
1
orless oil (588 mg, 36%). H NMR (400 MHz, [D5]pyridine): δ =
1.07 (m, 2 H), 1.18–1.30 (8 H), 1.43 (m, 2 H), 1.53–1.68 (4 H), 1.73
(m, 2 H), 1.82–2.04 (8 H), 3.64 (s, 3 H), 3.68 (d, J = 17.2 Hz, 1 H),
3.85 (d, J = 17.2 Hz, 1 H), 3.99 (m, 2 H), 4.15 (m, 2 H), 7.86 (d, J
= 8.4 Hz, 2 H) ppm. 13C NMR (75 MHz, [D5]): δ = 20.1, 25.5,
26.2, 28.2, 33.5, 33.6, 48.3, 52.2, 54.8, 62.3, 173.0, 173.4 ppm. IR
(film): ν = 2950–2900, 2858, 1741, 1658, 1642, 1529, 1200 cm–1.
˜
HRMS (TOF MS ES+): calcd. for C22H38N3O4 [M + H]+
408.2856; found 408.2863.
(R,S)-2,6-Bis(cyclohexylcarbamoyl)piperidin-1-yl-acetic Acid (12):
To a solution of 11 (98 mg, 0.24 mmol) in MeOH (3 mL) was added
a solution of KOH (4 m in H2O, 3 mL), and the reaction mixture
was stirred for 12 h at room temperature. The solution was then
diluted with H2O (10 mL), neutralized with 1 m aqueous HCl solu-
tion, and extracted with CH2Cl2 (4ϫ 4 mL). The combined organic
extracts were then dried with MgSO4, filtered, and concentrated
under reduced pressure to afford compound 12 (79 mg, 84%) as a
white amorphous solid. 1H NMR (300 MHz, [D5]pyridine): δ =
1.05 (m, 2 H), 1.18–1.45 (10 H), 1.52–1.70 (4 H), 1.78 (m, 2 H),
1.84–2.04 (8 H), 3.80 (d, J = 17.4 Hz, 1 H), 3.92 (d, J = 17.4 Hz,
1 H), 4.04 (m, 2 H), 4.20 (m, 2 H), 7.14 (br. s, 1 H), 8.09 (d, J =
7.2 Hz, 2 H) ppm. 13C NMR (75 MHz, [D5]pyridine): δ = 20.5,
25.4, 26.2, 27.6, 33.5, 33.6, 48.3, 55.3, 62.4, 173.2, 175.5 ppm. IR
[5] For a recent review on the reactions of isocyanides with imin-
ium ions beyond the Ugi reaction, see: L. El Kaim, L. Gri-
maud, Tetrahedron 2009, 65, 2153–2171.
[6] Glutaraldehyde was recently used as a lysine surrogate in bio-
mimetic synthesis (in theory it could arise from oxidative deam-
ination of aminopentanal). See for example: a) L.-H. Yan, F.
Dagorn, E. Gravel, B. Séon-Méniel, E. Poupon, Tetrahedron
2012, 68, 6276–6283; b) R. Salame, E. Gravel, P. Retailleau, E.
Poupon, Org. Bioorg. Chem. 2010, 8, 2522–2528 and references
cited therein.
[7] For examples of isocyanide additions to pyridinium salts and
dihydropyridines, see: a) N. A. O. Williams, C. Masdeu, J. L.
Díaz, R. Lavilla, Org. Lett. 2006, 8, 5789–5792; b) C. Masdeu,
E. Gómez, N. A. Williams, R. Lavilla, QSAR Comb. Sci. 2006,
25, 465–473; c) C. Masdeu, E. Gómez, N. A. O. Williams, R.
Lavilla, Angew. Chem. 2007, 119, 3103; Angew. Chem. Int. Ed.
2007, 46, 3043–3046.
[8] Cascade reactions in total synthesis, selected review articles: a)
E. A. Anderson, Org. Biomol. Chem. 2011, 9, 3997–4006; b)
K. C. Nicolaou, J. S. Chen, Chem. Soc. Rev. 2009, 38, 2993–
3009; c) E. Poupon, E. Gravel, Eur. J. Org. Chem. 2008, 27–42;
d) K. C. Nicolaou, D. J. Edmonds, P. G. Bulger, Angew. Chem.
2006, 118, 7292; Angew. Chem. Int. Ed. 2006, 45, 7134–7186.
[9] Multicomponent reactions in total synthesis, review article:
B. B. Touré, D. G. Hall, Chem. Rev. 2009, 109, 4439–4486.
Received: October 5, 2012
(film): ν = 2950–2900, 2857, 1643, 1642, 1527, 1451 cm–1. HRMS
˜
(TOF MS ES+): calcd. for C21H36N3O4 [M + H]+ 394.2700; found
394.2704.
(R,S)-[2,6-Bis(cyclohexylcarbamoyl)piperidin-1-yl-acetyl]-(2-phenyl-
ethyl)amine (13): To a solution of 12 (65 mg, 0.17 mmol) and 2-
phenylethylamine (20 mg, 0.17 mmol, 1 equiv.) in CH3CN (4 mL)
was added EDC hydrochloride (38 mg, 0.2 mmol, 1.2 equiv.),
HOBt (27 mg, 0.2 mmol, 1.2 equiv.), and triethylamine (89 μL,
0.66 mmol, 3.8 equiv.). After stirring for 12 h at room temperature,
the reaction mixture was extracted with CH2Cl2 (3ϫ 5 mL). The
Published Online: December 10, 2012
Eur. J. Org. Chem. 2013, 453–455
© 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
455